Research Results of Luye Pharma’s Next-Generation VMAT2 Inhibitor LY03015 Published in Eu...

The results demonstrate LY03015’s high binding affinity for VMAT2 and excellent inhibition of DA uptake, indi...

Boan Biotech’s Dulaglutide Injection (BA5101) Approved for Clinical Trials in China

For glycemic control in adult patients with type 2 diabetes.

Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platf...

Luye Pharma’s Rivastigmine Multi-Day Transdermal Patch Receives Marketing Approval in the...

For the treatment of mild to moderate dementia associated with Alzheimer’s disease

Luye Pharma’s Goserelin Microsphere Formulation Meets Preset Endpoints in Phase III Clini...

New Indication for Boan Biotech’s Boyounuo (Bevacizumab Injection) Approved in China

Treatment of Recurrent Glioblastoma